Pré-Programme
Keynote lecture:
Shai Izraeli (University of Tel-Aviv, Israel)
JAK-STAT driven "Ph-like" ALL - what biology may teach us about therapy
Oratrices/orateurs confirmé(e)s
Raphael Itzykson (Department of Hematology and Immunology, Hopital Saint-Louis, AP-HP & Université de Paris, INSERM UMR944 Saint-Louis Research Institute, Paris)
Clinical Relevance of Clonal Architecture in Leukemias
Els Verhoeyen (Université Côte d’Azur, C3M, Equipe ‘Cancer et metabolism’ – NICE
et International center for research in infectiology CIRI – EVIR, Lyon)
GAPDH over-expression in the T cell lineage leads to a rare T cell lymphoma through a NF-κB dependent mechanism
Isidro Sánchez-García (Instituto de Biología Molecular y Celular del Cáncer-IBMCC (CSIC-USAL). Salamanca, Spain)
A consensus model for the causation of childhood B cell precursor ALL
Julien Bertrand (Université de Genève, Suisse)
How to expand HSCs: a tale of zebrafish tails
Adam J Mead (Radcliffe Department of Medicine, Oxford, England)
Title to be announced
Elodie Segura (INSERM U932, Institut Curie, Paris)
Mechanisms of monocyte differentiation in steady-state and inflammation.
Elisa Laurenti (Wellcome - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, England)
Functional and molecular diversity of the human haematopoietic stem cell compartment
Michaela Fontenay (Institut Cochin, Paris)
A novel role for splicing factor SF3B1 in the control of DNA replication in erythropoiesis: the lessons of myelodysplastic syndromes with ring sideroblasts.
Claire Francastel (Université de Paris Diderot, Paris)
DNA methylation and disease: perspectives from the study of rare genetic disorders
Session « jeunes recruté.e.s aux concours des chercheurs de la Recherche Publique»
En cours de préparation